ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
AJU GEORGE M.D.

Internal Medicine

23,630

$775K

1130
886 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $56

LUIS FERNANDEZ MD

Internal Medicine

23,571

$1.34M

1238
1018 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

JOSE DEUS-FERNANDEZ MD

Internal Medicine

23,564

$702K

848
783 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $56

JOSE MARICHAL M.D.

Internal Medicine

23,554

$1.2M

716
633 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

JOSE SOLER MD

Internal Medicine

23,439

$513K

856
704 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$22
Average prescription price

Avg: $56

DIGESH CHOKSHI M.D.

Internal Medicine

23,437

$864K

809
678 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

MAHENDER REDDY MD

Internal Medicine

23,403

$732K

864
768 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $56

LEOPOLDO FORMOSO MD

Internal Medicine

23,391

$800K

622
579 are 65+

N/A
N/A

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

JUAN AGUILAR-CHACON M.D.

Internal Medicine

23,387

$958K

709
668 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $56

RENALDAS SMIDTAS MD

Internal Medicine

23,385

$1.14M

796
623 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

ELIAS FEANNY MD

Internal Medicine

23,200

$1.32M

908
785 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

STEVEN RAPP M.D.

Internal Medicine

23,144

$774K

991
913 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $56

RAJANKUMAR NAIK MD

Internal Medicine

23,101

$695K

1779
1329 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $56

ESTEBAN RUIZ MD

Internal Medicine

23,088

$1.18M

891
687 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

OSCAR SARAVIA MD

Internal Medicine

23,067

$859K

844
803 are 65+

N/A
N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

IDALMIS TERAN-GONZALEZ M.D.

Internal Medicine

22,990

$540K

762
686 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$24
Average prescription price

Avg: $56

ALEX GONZALES MD

Internal Medicine

22,932

$1.5M

737
492 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

JOHN LOPERA MD

Internal Medicine

22,927

$481K

979
878 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$21
Average prescription price

Avg: $56

LUIS AGUIAR M.D.

Internal Medicine

22,762

$786K

713
668 are 65+

N/A

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $56

JAYAPRAKASH SHETTY MD

Internal Medicine

22,681

$1.15M

845
586 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

ARIEL RAMIREZ NAVARRO MD

Internal Medicine

22,642

$1.09M

678
608 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $56

KEVIN GILBERT MD

Internal Medicine

22,632

$674K

1014
915 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $56

RICARDO CALONGE M.D.

Internal Medicine

22,608

$1.36M

761
722 are 65+

N/A

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

MYEONG KANG MD

Internal Medicine

22,591

$1.07M

1222
1016 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $56

GABRIEL SOLTI GRASZ MD

Internal Medicine

22,578

$384K

1641
1427 are 65+

N/A

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank